The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

New England Journal of Medicine

Volumn 346, Issue 25, 2002, Pages 1937-1947

  Rosenwald, Andreas ^a   Wright, George ^b   Chan, Wing C ^a,c   Connors, Joseph M ^d   Campo, Elias ^e   Fisher, Richard I ^f   Gascoyne, Randy D ^d   Konrad Muller Hermelink, H ^g   Smeland, Erlend B ^h   Giltnane, Jena M ^a   Hurt, Elaine M ^a   Zhao, Hong ^a   Averett, Lauren ^a   Yang, Liming ^a   Wilson, Wyndham H ^a   Jaffe, Elaine S ^a   Simon, Richard ^a   Klausner, Richard D ^a   Powell, John ⁱ   Duffey, Patricia L ^j   Longo, Dan L ^j   Greiner, Timothy C ^k   Weisenburger, Dennis D ^k   Sanger, Warren G ^k   Dave, Bhavana J ^k   Lynch, James C ^k   Vose, Julie ^k   Armitage, James O ^k   Montserrat, Emilio ^e   López Guillermo, Armando ^e   Grogan, Thomas M ^l   Miller, Thomas P ^l   Leblanc, Michel ^m   Ott, German ^g   Kvaloy, Stein ^h   Delabie, Jan ^h   Holte, Harald ^h   Krajci, Peter ^h   Stokke, Trond ^h   Staudt, Louis M ^a   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b Biometric Research Branch   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^e UNIVERSITY OF BARCELONA   (Spain)

^f UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^g UNIVERSITY OF WÜRZBURG   (Germany)

^h OSLO UNIVERSITY HOSPITAL   (Norway)

ⁱ NATIONAL INSTITUTES OF HEALTH   (United States)

^j NATIONAL INSTITUTE ON AGING   (United States)

^k UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^l UNIVERSITY OF ARIZONA   (United States)

^m Southwest Oncology Group   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DNA; DOXORUBICIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PREDNISONE; PROTEIN BCL 2; TRANSCRIPTION FACTOR REL; VINCRISTINE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE ACTIVATION; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CELL PROLIFERATION; CELL TYPE; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DNA FINGERPRINTING; DNA MICROARRAY; FEMALE; GENE AMPLIFICATION; GENE CLUSTER; GENE CONSTRUCT; GENE EXPRESSION REGULATION; GENE TRANSLOCATION; GENETIC DISORDER; GENETIC RISK; GERMINAL CENTER; HISTOPATHOLOGY; HUMAN; IMMUNOCOMPETENT CELL; LARGE CELL LYMPHOMA; LYMPH NODE CELL; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOLECULAR BIOLOGY; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; STROMA CELL; TUMOR BIOPSY;

ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0037142053     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa012914     Document Type: Article

References (17)

1. Diffuse large cell lymphoma
2. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma
3. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
4. The International non-Hodgkin's lymphoma prognostic factors project. A predictive model for aggressive non-Hodgkin's lymphoma
5. International consensus conference on high-dose therapy with hematopoietic stem cell transplantation in aggressive non-Hodgkin's lymphomas: Report of the jury
6. The Lymphochip: A specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes
7. The use of real-time quantitative polymerase chain reaction and comparative genomic hybridization to identify amplification of the REL gene in follicular lymphoma
8. Detection of occult follicular lymphoma by specific DNA amplification
9. Cluster analysis and display of genome-wide expression patterns
10. Signatures of the immune response
11. The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile
12. Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67
13. Cell proliferation as a long-term prognostic factor in diffuse large-cell lymphomas
14. HLADR (Ia) immune phenotype predicts outcome for patients with diffuse large cell lymphoma
15. Connective tissue growth factor: A mediator of TGF-beta action on fibroblasts
16. Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells
17. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB